Value_Investor
20 hours ago
Who are selling so many Dirt Cheap shares at such Ridiculous-Low price levels? Why? At the Bottom this Diamond-In-Rough only has less than Mere $235,543 Incredible-Low Market Value (MV)! During my decades of OTC stocks investment experience, I've never seen a Very Valuable Extra-NASDAQ-Bio-Tech stock (some AI application estimates $12M worthy Intangible Assets which are not included in the latest financial balance sheet) could crash to as low as VINC! For example, its Same Winding-Down OTC peer (TTO*: 28.3M shares Large OS) has -$12M Huge NEGATIVE Net Asset but at its Bottom $0.056 it still has $1,584,906 Large MV which is Shocking 6.73 Times of the MV of VINC at its Bottom $0.045 while VINC has $15M Huge POSITIVE Net Asset! Why?
At its THREE-Days-Bouncing-High $0.259 that peer has $7,330,189 Huge MV which equals to the MV of VINC at $1.400421!
Note, $1.400421 = 31.1203 Times of its GIANT-Discount Bottom price $0.045! Which means this Hidden Gem can Easily And Quickly soar 31.1203-Bagger Within just a couple of days...
So, VINC is Super Undervalued now!
It is also at Hyper Oversold status --- from $10.4 to $0.045 within just a couple of months!
Value_Investor
2 days ago
How high this Diamond-In-Rought will hit? Based on its Exactly Same-Type of Bio-Tech Winding-Down OTC peer (TOXIC DELINQUENT LIMITED-Information-tier TTO* has 28,301,887 shares Large OS) did most recently --- from its Bottom $0.056 to $0.259, VINC (FULLY-REPORTING CURRENT-Information-tier with Only Mere 5,234,277 shares Tiny OS) will surge to $1.400421 (in the coming days) which is 31.121 Times of its Bottom $0.045 because the MV of its peer at $0.259 = the MV of VINC at $1.400421!
Note, the TOXIC DELINQUENT LIMITED-Information-tier peer has HUGE NEGATIVE Net Asset --- -$11,710,000 HUGE DEBTS vs. this Sought-After FULLY-REPORTING Current-Information-tier VINC has LARGE POSITIVE Net Asset --- +$2,724,000 LARGE Equity Value!
The TOXIC DELINQUENT LIMITED-Information-tier peer has only $2,083,000 LARGE Cash vs. this Sought-After FULLY-REPORTING Current-Information-tier VINC has $4,987,000 HUGE Cash!
Value_Investor
6 days ago
Wow, that CH7-Bankrupt OTC Junk Bio-Tech peer (TTO?) has -$11,710,000 HUGE NEGATIVE Net Asset or Shareholder's Equity Value but it just did hit Shocking-High $7,330,188.733 Huge Market Value just a month ago!
To match the Same Market Value, VINC (5,234,277 shares FIXED TINY OS now) will bounce up to $1.400421 which is 5.1 Times of its current Ridiculous-Low price $0.275!
Note, the most recent high was $10.4 with about the Same financial balance sheet from the second chart below!
Hyper Oversold status --- from nearly $140 (see the first chart below) to Super-Ridiculous-Low 52-week-low $0.22!
Super Undervalued now based on its Huge Cash Value and High Book Value!
Value_Investor
4 weeks ago
LOL, even a Risky OTC-Market CH7-Bankrupt Garbage (TTOO) could surge to Ridiculous High $0.259 (on 02/21/25) Within just THREE Trading-Sessions from its Highly Inflated Bottom $0.056 (on 02/18/25) with 28,301,887 shares Large OS vs. this Innovative NASDAQ Bio-Tech Hidden Gem (VINC) was trading at as low as $0.486 with only Mere 2,239,580 shares Super Tiny OS!
Based on the Market Value match alone, buying the CH7 Junk at $0.259 = buying VINC at $3.2731 which is 5.95 Times of its current Ridiculous Low price $0.55! Not to mention that this Diamond-In-Rough has $5.43 a share Huge POSITIVE Book Value and $6.323 a share Huge POSITIVE Merger Value (see the link below)! Based on the Minimal $14.16 Millions dollars of Buy-Out deal below and 2,239,580 shares Super TINY OS count, every common share of VINC is worthy $6.323!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
So, it will be Very Easy for VINC to surge over 01/28/25's Premarket-High $3.35 (which is still far below its Book Value $5.43)!
Note, VINC did bounce up to $3.502 in the After-Hours session on 01/16/25!
Thus, VINC is Super Undervalued now! Easy to run 10-Bagger Quick Huge Rally in the coming days...
Also, VINC is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.486!
Value_Investor
1 month ago
Great Reverse-Merger News (see the link below) today! The bid is already up to $1.31 so far!
https://finance.yahoo.com/news/vincerx-pharma-announces-non-binding-125200530.html
Based on the $15 Millions dollars of Buy-Out deal above and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.7! So, it might test its most recent high $10.4 again as soon as today...
VINC has $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech v.s. it is trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24), LOL! Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!
So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value $5.43!
Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!
So, this Hidden Gem (VINC) is Super Undervalued now!
Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!
Value_Investor
1 month ago
Could anyone explain why a $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech stock was trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24)? Why is it? Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!
So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value [color=green]$5.43!
Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!
Based on the Minimal $14.16 Millions dollars of Buy-Out deal below and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.323!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
So, this Hidden Gem (VINC) is Super Undervalued now!
Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!
Value_Investor
2 months ago
VINC just released a Good News in After-Hours after the market close --- see the link below!
https://ih.advfn.com/stock-market/NASDAQ/vincerx-VINC/stock-news/95460166/form-8-k-current-report
On February 11, 2025, Vincerx Pharma, Inc. (the “Company”) received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share. Nasdaq notified the Company in the Compliance Notice that, from January 28, 2025 to February 10, 2025, the closing bid price of the Company’s common stock had been $1.00 per share or greater and, accordingly, the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter was now closed.
The POSITIVE Huge Book Value is $5.43 a share vs. the stock is trading at Ridiculous-Low price levels $1.28 now, LOL! Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value!
Note, on January 16, 2025, VINC did bounce to $3.502 in the After-Hours session!
Every common share of VINC is worthy $6.323 based on the Minimal $14.16 Millions dollars of Buy-Out deal and 2,239,580 shares Super Tiny OS count!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
This Diamond-In-Rough is at Hyper Oversold status --- from 12/30/2024's $10.4 to New Bottom $1.18!
So, this Hidden Gem is Super Undervalued now!
Value_Investor
2 months ago
It is Super Hard to understand why this Hidden Gem has $5.4286 per share Huge POSITIVE Book Value but it is trading at such Ridiculous-Low or Huge Discount price levels $1.3x ~ $1.4x?
If I had $3,045,828.80 cash at hand then I'm willing to Buy-Out the Entire OS at current Huge Discount Dirt Cheap price $1.36 because 2,239,580 x $1.36 = $3,045,828.80!
georgie18
3 months ago
VINC...$1.69...🥳
georgie18
Member Level
Re: None
Saturday, February 01, 2025 3:12:37 PM
Post#
31347
of 31358
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...
georgie18
Member Level
Re: georgie18 post# 31
Wednesday, January 29, 2025 8:28:50 AM
Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
georgie18
3 months ago
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...
georgie18
Member Level
Re: georgie18 post# 31
Wednesday, January 29, 2025 8:28:50 AM
Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
georgie18
3 months ago
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
Value_Investor
3 months ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the seventh, eighth, and nineth Bad news for VINC:
"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3095233
"Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3098961
"Up to 1:20 Big R/S" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18036191&guid=Qs0-kKDmXUvnJth
"16,356,210 shares of Huge New FREE dilutions" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18074105&guid=Qs0-kKDmXUvnJth
So, we should see A Series Of New 52-Week-Lows until VINC hits the Final Bottom $0.025...
Are you kidding? "The next Misrosoft|? No way! The best situation is to avoid to file the BANKRUPTCY! I wish "No Bankruptcy" here so that we could see a "Dead-Cat Bounce" sometime this year!
Value_Investor
3 months ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the fourth, fifth, and sixth Bad news for VINC:
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089437
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3092088
"VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3093920
Value_Investor
3 months ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the first, second, and third Bad news for VINC:
"Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087853
"VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087906
"STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - VINC, VCSA, MRNS, MHLD" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089161
georgie18
4 months ago
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
georgie18
4 months ago
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ask ADVFN Intelligence (AI)
Renee
4 days ago
frans
3 weeks ago
Monksdream
1 month ago
glenn1919
2 months ago
SmokeSignals
4 months ago
Hot Features
Premium
